Medicinal products with the active ingredient Natalizumab
Status
Active
Submission Deadline
722 days remaining
Contracting authority
AOK Sachsen - Anhalt102 more open tenders view
Location
Magdeburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-513599-2026
Source
Conclusion of non-exclusive discount agreements according to § 130a Abs. 8 SGB V for finished medicinal products containing the active ingredient Natalizumab (ATC: L04AG03) within an open-house model. Contracts can be concluded at any time with any qualified pharmaceutical company under the same conditions, without exclusivity or individual negotiations. The earliest contract start date is 01.10.2026, with a maximum contract duration of 24 months, ending on 30.09.2028. This publication does not constitute the award of a public contract according to § 103 GWB.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 513599-2026HTML
- TED PDF — 513599-2026PDF
- TED XML — 513599-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024